Sponsored
Machine Learning in Drug Development: Part 1 - (Annual Reports in Medicinal Chemistry) by Katherine Seley-Radtke (Hardcover)
Pre-order
Sponsored
About this item
Highlights
- Machine Learning in Drug Development: Part One, Volume 64 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field.
- Author(s): Katherine Seley-Radtke
- 176 Pages
- Science, Chemistry
- Series Name: Annual Reports in Medicinal Chemistry
Description
Book Synopsis
Machine Learning in Drug Development: Part One, Volume 64 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field. Chapters in this release include Artificial Intelligence in Small Molecule and Nucleic Acid Research: A Review, AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization, AI-aided Drug Development for Protein Degraders: Biology Validation, Disease-association, Drug Repurposing, Transforming Modern Drug Discovery with Machine Learning, Artificial Intelligence in the Development of Antiviral Drugs: Progress and Applications, Artificial Intelligence for Drug Target Identification, and Machine Learning in Proteomic Biomarker Discovery.